SPRINGER NATURE
1. Casirivimab/imdevimab lack of efficacy against COVID-19 Omicron variant
Reactions Weekly (2022)
https://link.springer.com//content/pdf/10.1007%2Fs40278-022-08680-z.pdf
2. The Emergence of the Omicron (B.1.1.529) SARS-CoV-2 Variant: What is the Impact on the Continued Pandemic?
Jaffar A. Al-Tawfiq, Van-Thuan Hoang… in Journal of Epidemiology and Global Health (2022)
https://link.springer.com//content/pdf/10.1007%2Fs44197-022-00032-w.pdf
3. Omicron: a mysterious variant of concern
A. Gowrisankar, T. M. C. Priyanka, Santo Banerjee in The European Physical Journal Plus (2022)
https://link.springer.com//content/pdf/10.1140%2Fepjp%2Fs13360-021-02321-y.pdf
4. The Emergence of Omicron: Challenging Times Are Here Again!
Tanu Singhal in Indian Journal of Pediatrics (2022)
https://link.springer.com//content/pdf/10.1007%2Fs12098-022-04077-4.pdf
5. Role of Omicron variant of SARS-CoV-2 in children in Germany
Stefan Bittmann in World Journal of Pediatrics (2022)
https://link.springer.com//content/pdf/10.1007%2Fs12519-021-00511-3.pdf
6. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
Maren Schubert, Federico Bertoglio, Stephan Steinke, Philip Alexander Heine… in BMC Medicine (2022)
https://link.springer.com//content/pdf/10.1186%2Fs12916-022-02312-5.pdf
7. Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load
Jorge Quarleri, Veronica Galvan, M. Victoria Delpino in GeroScience (2022)
https://link.springer.com//content/pdf/10.1007%2Fs11357-021-00500-4.pdf
8. Molecular SARS-CoV-2 surveillance in Bavaria shows no Omicron transmission before the end of November 2021
Jennifer Flechsler, Ute Eberle, Alexandra Dangel, Sabrina Hepner, Clara Wimmer… in Infection (2022)
https://link.springer.com//content/pdf/10.1007%2Fs15010-022-01767-1.pdf
9. Impaired detection of omicron by SARS-CoV-2 rapid antigen tests
Andreas Osterman, Irina Badell, Elif Basara… in Medical Microbiology and Immunology (2022)
https://link.springer.com//content/pdf/10.1007%2Fs00430-022-00730-z.pdf
SCIENCEDIRECT
1. Fending off Delta - Hospital measures to reduce nosocomial transmission of COVID-19
International Journal of Infectious Diseases, 4 February 2022, Volume 117 (Cover date: April 2022), Pages 139-145
Rachel Hui Fen LIM, Htet Lin HTUN, Angela CHOW
https://www.sciencedirect.com/science/article/pii/S1201971222000777/pdfft?md5=d85f1a6b582b59f45341c331e43c470b&pid=1-s2.0-S1201971222000777-main.pdf
2. Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India
Microbial Pathogenesis, 19 January 2022, Volume 164 (Cover date: March 2022), Article 105404
Pushpendra Singh, Kuldeep Sharma, Nitin M. Nagarkar
https://www.sciencedirect.com/science/article/pii/S0882401022000171/pdfft?md5=ce9a8d3786a0a520ec844bf0b17ab391&pid=1-s2.0-S0882401022000171-main.pdf
3. Modeling and optimal control of mutated COVID-19 (Delta strain) with imperfect vaccination
Chaos, Solitons & Fractals, 31 January 2022, Volume 156 (Cover date: March 2022), Article 111825
Tingting Li, Youming Guo
https://www.sciencedirect.com/science/article/pii/S0960077922000364/pdfft?md5=582b7f8dbf65e45fa1d8f2c343b37011&pid=1-s2.0-S0960077922000364-main.pdf
4. Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant–infected patients in Jiangsu, China
International Journal of Infectious Diseases, 19 January 2022, Volume 116 (Cover date: March 2022), Pages 204-209
Zhiliang Hu, Bilin Tao, Jianming Wang
https://www.sciencedirect.com/science/article/pii/S1201971222000339/pdfft?md5=243821a5bcf29c0bf9a2d53fb665e894&pid=1-s2.0-S1201971222000339-main.pdf
5. Changes in infectivity, severity and vaccine effectiveness against delta COVID-19 variant ten months into the vaccination program: The Israeli case
Preventive Medicine, 17 November 2021 ,Volume 154 (Cover date: January 2022), Article 106890
Mor Saban, Vicki Myers, Rachel Wilf-Miron
https://www.sciencedirect.com/science/article/pii/S0091743521004631/pdfft?md5=86be23907a1169e9b05113116febfff6&pid=1-s2.0-S0091743521004631-main.pdf
6. Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study
The Lancet Regional Health - Europe, 28 October 2021, Volume 12 (Cover date: January 2022), Article 100252
Hester Allen, Amoolya Vusirikala, Meaghan Kall
https://www.sciencedirect.com/science/article/pii/S2666776221002386/pdfft?md5=d8ead76b2c31b593bf4284237a84cef1&pid=1-s2.0-S2666776221002386-main.pdf
7. Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study
The Lancet Respiratory Medicine, Available online 25 February 2022, In press, corrected proof
Paul M McKeigue, David A McAllister, Helen M Colhoun
https://www.sciencedirect.com/science/article/pii/S2213260022000455/pdfft?md5=0879a789fe5fe944a329e8e64ec23c6e&pid=1-s2.0-S2213260022000455-main.pdf
8. Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas
The American Journal of Pathology, 11 November 2021, Volume 192, Issue 2 (Cover date: February 2022), Pages 320-331
Paul A. Christensen, Randall J. Olsen, James M. Musser
https://www.sciencedirect.com/science/article/pii/S0002944021004806/pdfft?md5=54059817be9e9c7d408a640ff6e90819&pid=1-s2.0-S0002944021004806-main.pdf
9. Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant
Mayo Clinic Proceedings, 16 December 2021, Volume 97, Issue 2 (Cover date: February 2022), Pages 327-332
John C. O’Horo, Douglas W. Challener, Raymund R. Razonable
https://www.sciencedirect.com/science/article/pii/S0025619621009241/pdfft?md5=1cadf5f488530d03a2ad4dddaf8c3ae1&pid=1-s2.0-S0025619621009241-main.pdf
10. Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant
Pathology ,Available online 31 January 2022, In press, corrected proof
Adriana E. Rosato, Engy Msiha, Roberto R. Rosato
https://www.sciencedirect.com/science/article/pii/S0031302522000356/pdfft?md5=ca8997c9cc9944ab4fbd2a19b85de64c&pid=1-s2.0-S0031302522000356-main.pdf
11. Contact tracing period and epidemiological characteristics of an outbreak of the SARS-CoV-2 Delta variant in Guangzhou
International Journal of Infectious Diseases, 29 January 2022, Volume 117 (Cover date: April 2022), Pages 18-23
Xiaowei Ma, Keyi Wu, Xianbo Wu
https://www.sciencedirect.com/science/article/pii/S1201971222000364/pdfft?md5=c24edc9db32a52842d0f417ba3de8a3b&pid=1-s2.0-S1201971222000364-main.pdf
12. Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants
eBioMedicine, 17 December 2021, Volume 75 (Cover date: January 2022), Article 103761
Rüdiger Groß, Michelle Zanoni, Janis A. Müller
https://www.sciencedirect.com/science/article/pii/S2352396421005557/pdfft?md5=84752304812a2d77efbff57e2892aa85&pid=1-s2.0-S2352396421005557-main.pdf
13. Neutralizing antibody activity against the B.1.617.2 (delta) variant 8 months after two-dose vaccination with BNT162b2 in health care workers
Clinical Microbiology and Infection, Available online 3 February 2022, In press, corrected proof
Louise Benning, Christian Morath, Claudius Speer
https://www.sciencedirect.com/science/article/pii/S1198743X22000350/pdfft?md5=23056daf8465068b4189dc1179fc96d9&pid=1-s2.0-S1198743X22000350-main.pdf
14. SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant
Infectious Disease Clinics of North America, Available online 1 February 2022, In press, journal pre-proof
Eric A. Meyerowitz, Aaron Richterman
https://www.sciencedirect.com/science/article/pii/S0891552022000174/pdfft?md5=5d16ecc1cb84b36e711af7e2d70a1139&pid=1-s2.0-S0891552022000174-main.pdf
15. Molecular dynamics simulations of the delta and omicron SARS-CoV-2 spike – ACE2 complexes reveal distinct changes between both variants
Computational and Structural Biotechnology Journal, 26 February 2022, Volume 20 (Cover date: 2022), Pages 1168-1176
Eileen Socher, Lukas Heger, Philipp Arnold
https://www.sciencedirect.com/science/article/pii/S2001037022000551/pdfft?md5=be588312d3378f3e5d71bd78c97bde04&pid=1-s2.0-S2001037022000551-main.pdf
16. Model-based assessment of SARS-CoV-2 Delta variant transmission dynamics within partially vaccinated K-12 school populations
The Lancet Regional Health - Americas, 25 November 2021, Volume 5 (Cover date: January 2022), Article 100133
Jennifer R. Head, Kristin L. Andrejko, Justin V. Remais
https://www.sciencedirect.com/science/article/pii/S2667193X21001290/pdfft?md5=288c40f9ebeca1e72f60b14b74d70cb7&pid=1-s2.0-S2667193X21001290-main.pdf
Các công bố về COVID-19 trước thời gian trên:
Cập nhật các công bố về COVID-19 từ ngày 25/03 đến ngày 04/03/2022
https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nhung-nghien-cuu-phan-tich-ve-covid-19-ngay-25-2-4-3-2022-4729.html
Cập nhật các công bố về COVID-19 từ ngày 18/02 đến ngày 25/02/2022
https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/vac-xin-covid-19-va-nhung-xu-huong-nghien-cuu-ngay-18-2-25-2-2022-4707.html
Cập nhật các công bố về COVID-19 từ ngày 11/02 đến ngày 18/02/2022
https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/covid-19-va-nhung-tac-dong-doi-voi-doi-song-ngay-11-18-2-2022-4685.html
Cập nhật các công bố về COVID-19 từ ngày 04/02 đến ngày 11/02/2022
https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-covid-19-tu-ngay-4-2-den-ngay-11-2-2022-4664.html
Cập nhật các công bố về COVID-19 từ ngày 21/01 đến ngày 28/01/2022
https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-21-01-den-ngay-28-01-2022-4639.html
Cập nhật các công bố về COVID-19 từ ngày 14/01 đến ngày 21/01/2022
https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-14-1-den-ngay-21-1-2022-4618.html
Cập nhật các công bố về COVID-19 từ ngày 7/01 đến ngày 14/01/2022
https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-7-1-den-ngay-14-1-2022-4601.html
Cập nhật các công bố về COVID-19 từ ngày 01/01 đến ngày 7/01/2022
https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nghien-cuu-moi-ve-vaccine-covid-19-tu-ngay-3-1-den-ngay-7-1-2022-4584.html